Fig. 2.

Summary of the Vδ1 and Vδ2 γδ T cell absolute counts in CML patients at diagnosis (CML dg., n = 40) and during the TKI therapy (open circles) compared to healthy donors (n = 40, black circles). PBMC samples were analyzed at diagnosis and at 3 months (CML + 3), 6 months (CML + 6), 12 months (CML + 12) and 18 months (CML + 18) for Vδ1 (A) and Vδ2 (B) γδ T cells. The median values are shown. Statistically significant differences are presented as **** p < 0.0001, *** p = 0.0001. Absolute leukocyte counts (C) and absolute lymphocyte counts (D) and absolute counts of αβ T cells (E) are shown with median values during the patient follow-up